ANTHONY NOLAN
Anthony Nolan saves the lives of people with blood cancer. By growing our register of stem cell donors, conducting research and providing outstanding support to patients, Anthony Nolan cures people's blood cancer and blood disorders. But we need to do more. Without you, there is no cure.
Financial health, per its FY2025 accounts
The accounts state that the charity generated a net deficit of £0.6m for the year, with total income of £70.8m and total expenditure of £71.4m. Free reserves remained at £8.0m, which is at the lower end of the trustees' stated policy range of £8m to £12m. The trustees confirm that the charity has adequate resources to continue in operation for the foreseeable future.
What the accounts disclose
“85% provision of stem cells”
“The Trustees have determined that the optimal level for free reserves is between £8m and £12m”
“The charity has one wholly owned subsidiary, Anthony Nolan Trading Limited (“ANTL”)” — page 84
In the news
- 'He wouldn't be alive today' - work pals to climb the Big One for lifesaving Anthony Nolan Trust
- OE Ollie Delivers Powerful Talk Raising Awareness For Anthony Nolan Trust
- Anthony Nolan Trust: SFRS staff sign up pupils from St Mungo's High in Falkirk as potential life-savers
Corporate structure
- Registered company of the charity Companies House 02379280
Leadership, per the charity’s website
- Henny Braund MBE — Chief Executive
- Nic Alderson — Chief Operating Officer
- Ian Deans — Chief Financial Officer
- Nicky Read — Chief of Fundraising
- Dr Robert Danby — Chief Medical and Scientific Officer
- Caitlin Farrow — Director of Strategy and Influencing
- Ann O'Leary — Director of Donor and Transplantation Services
Company officers (Companies House)
- MCMANUS, Philomena on trustee list
- LEEMING, Robert Antony Dundas on trustee list
- RAMAGOPALAN, Sreeram, Dr on trustee list
- POTTER, Victoria Therese, Dr on trustee list
- LEE, Deborah Clare on trustee list
- CONROY, Susan Esther, Dr on trustee list
- MILLER, Matthew James Barrington on trustee list
- HORLICK, Nicola Karina Christina on trustee list
- RITSON, Mark on trustee list
- LAWS, Martin John Hallam on trustee list
- DURLING, Samantha Emily
Public-sector contracts awarded
| Buyer | Contract | Awarded | Value |
|---|---|---|---|
| UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST | WPL06866 - Donor Search and Provision Service | — | — |
UK research funding (UKRI Gateway to Research)
- Pre-clinical development of a hematopoietic stem cell therapy product
- Dissecting the functional impact of natural killer cell receptor variation in cattle.
- Miniaturisation of high throughput healthcare bioreactors for advanced therapeutics
- Explore the impact of genetic variation on the livestock immune response to pathogens
- SMARTCell: Scalable Manufacture of Advanced Regenerative Therapeutics - Cell Therapies
- IAH Fellowship:Using comparative genetics to investigate ruminant NK cell receptor evolution and function
Property (HM Land Registry)
Advertised salaries (public job ads)
- Brand & Insight Manager — £39,000 per year
- Supporter-Led Fundraising Coordinator — £32,249 per year
Structured financials (annual return, FY ending 31/03/2025)
Register events
- Received assets from another charity (07/11/2025)
- Received assets from another charity (22/10/2018)
- Received assets from another charity (12/02/2018)
Trustees
- Nicola Karina Christina Horlickchair
- Deborah Clare Lee
- Dr Susan Esther Conroy
- Dr Victoria Therese Potter
- Mark Ritson
- Martin John Hallam Laws
- Matthew Graham-Hyde
- Matthew James Barrington Miller
- PHILOMENA MCMANUS
- Robert Antony Dundas Leeming
- Sreeram Ramagopalan
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £70.8m | £71.4m |
| 31/03/2024 | £63.0m | £64.9m |
| 31/03/2023 | £58.6m | £60.1m |
| 31/03/2022 | £53.5m | £53.0m |
| 31/03/2021 | £51.4m | £51.1m |
Common questions
Is ANTHONY NOLAN financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a net deficit of £0.6m for the year, with total income of £70.8m and total expenditure of £71.4m. Free reserves remained at £8.0m, which is at the lower end of the trustees' stated policy range of £8m to £12m. The trustees confirm that the charity has adequate resources to continue in operation for the foreseeable future. Its FY2025 accounts were audited by BDO LLP.
Who funds ANTHONY NOLAN?
Funders whose own accounts filings name ANTHONY NOLAN as a grant recipient include DAVID & RUTH LEWIS FAMILY CHARITABLE TRUST, GARFIELD WESTON FOUNDATION, RSM UK FOUNDATION, C A REDFERN CHARITABLE FOUNDATION, MASON MEDICAL RESEARCH TRUST.
Known funders
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE PENNIES FOUNDATION | 2 | £395k |
| PEACOCK CHARITABLE TRUST | 2 | £265k |
| DAVID LISTER CHARITABLE TRUST | 2 | £103k |
| INCORPORATED CHURCH INSTITUTE, UPPER TOOTING | 2 | £21k |
| THE WILLIE AND MABEL MORRIS CHARITABLE TRUST | 2 | £13k |
| JOHN SWIRE 1989 CHARITABLE TRUST | 2 | £4k |
| THE PAROCHIAL CHURCH COUNCIL OF THE ECCLESIASTICAL PARISH OF ST BRIDE FLEET STREET | 2 | £703 |
| ONE FOOTSTEP | 1 | — |
Charities like this
- Blood Cancer UK Research
- LEUKAEMIA & MYELOMA RESEARCH UK LTD
- BLOOD CANCER ALLIANCE
- Merseyside Against Blood Cancers
- VELINDRE UNIVERSITY NHS TRUST CHARITY
- DKMS FOUNDATION
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| ANTHONY NOLAN | £70.8m | — | — | within | — | no doubt |
| Blood Cancer UK Research | £21.1m | — | — | unclear | — | no doubt |
| LEUKAEMIA & MYELOMA RESEARCH UK LTD | £554k | — | 0 | unclear | — | noted |
| BLOOD CANCER ALLIANCE | £121k | — | 0 | unclear | — | no doubt |
| Merseyside Against Blood Cancers | £119k | — | 0 | unclear | — | no doubt |
| VELINDRE UNIVERSITY NHS TRUST CHARITY | £4.4m | — | 0 | above | — | no doubt |